Introduction {#s1}
============

Parameters of water diffusion in white matter derived from diffusion-weighted imaging (DWI), such as fractional anisotropy (FA), mean, axial, and radial diffusivity (MD, AD, and RD) are well-established markers of normal brain maturation ([@B1]--[@B5]) and ageing ([@B6]--[@B12]) and have been proposed as potential tools for the investigation of various brain disorders ([@B13]--[@B19]).

More recently, peak width of skeletonized mean diffusivity (PSMD) ([@B20]), a new phenotype of white matter microstructure that can be derived from DWI, has been proposed as an imaging biomarker of small vessel disease (SVD) ([@B20], [@B21]) and a correlate of cognitive impairment, particularly processing speed ([@B20]--[@B22]). Recall that PSMD is the difference between the 5th and the 95th percentiles of the distribution of the voxel MD value across a skeleton of the brain white matter. Note that PSMD is a dispersion statistic, as opposed to other diffusion tensor imaging (DTI) metric, such as AD, MD, RD, and FA, that are central tendency statistics. So far, our knowledge of the PSMD distribution in healthy individuals has been limited to these three previously mentioned studies that all included people aged over 50 years. In addition, none of these studies addressed the issue of changes in PSMD across lifespan, which is critical for establishing whether PSMD could be used as an imaging marker of brain aging as well as an early predictor of age-related disorders or to serve as a tool to monitor outcomes in clinical trials. Here, we gathered and analyzed cross-sectional DTI data from 10 population-based cohort studies to establish the time course, from post-adolescence to late adulthood, of the PSMD distribution and compare it with that of more commonly used white matter water diffusion phenotypes in white matter.

Materials and Methods {#s2}
=====================

Participants {#s2_1}
------------

Ten independent data sets coming from cross-sectional cohort studies were gathered in the present study, namely, MRi-Share, BIL&GIN, SYS, LIFE-Adult, 1000 BRAINS, UKBiobank, ASPSF, OATS, LBC1936, MAS (see acronym definition in [**Table 1**](#T1){ref-type="table"} caption). All but three (LIFE-Adult, 1000BRAINS, and UKBiobank) were part of the BRIDGET Consortium (BRain Imaging, cognition, Dementia, and next generation GEnomics: a Transdisciplinary approach to search for risk and protective factors of neurodegenerative disease), supported by EU-JPND (European Union Joint Programme---Neurodegenerative Disease Research). The 10 data sets included a total of 20,005 individuals (age range, 18.1 to 92.6 years; 10,807 women and 9,198 men). [**Table 1**](#T1){ref-type="table"} detail sample size and age distribution for the 10 cohorts that were all of cross.

###### 

Basic statistics for the 10 contributing data sets.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Data set                   MRi-Share              BIL&GIN          SYS              LIFE             1000 BRAINS      UKBiobank        ASPSF            OATS             LBC 1936         MAS              
  -------------------------- ---------------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ----------------
  **Sample size**            **20,005**             1,824            410              512              1,906            1,209            12,397           277              386              672              412

                             (% females)            72%              51%              54%              51%              44%              53%              60%              64%              47%              53%

  **Age (years)**            mean (SD)\             22.1 (2.3)\      26.9 (8.0)\      49.5 (5.0)\      58.1 (15.1)\     60.8 (13.4)\     62.6 (7.4)\      65.0 (11.1)\     71.1 (5.1)\      72.7 (0.7)\      80.3 (4.6)\
                             range                  \[18.1, 34.9\]   \[18.1, 57.2\]   \[36.4, 65.4\]   \[19.0, 82.0\]   \[18.5, 85.4\]   \[45.1, 80.3\]   \[38.5, 85.6\]   \[65.4, 89.5\]   \[71.0, 74.2\]   \[72.7, 92.6\]

  **TIV (cm^3^)**\           females\               1515 (104)\*\    1323 (93)\       1348 (164)\      1637 (115)\      1401 (104)\      1466 (203)\*\    1396 (110)\      1369 (133)\      1353 (100)\      1267 (141)\
  mean (SD)                  males                  1703 (118)\*     1503 (127)       1622 (131)       1831 (131)       1570 (118)       1576 (147)\*     1572 (118)       1574 (138)       1537 (112)       1460 (163)

  **(N) per age category**   **18 to 28** (2,200)   1,778            285              0                101              36               0                0                0                0                0

  **28 to 38** (340)         46                     84               3^†^             142              65               0                0                0                0                0                

  **38 to 48** (707)         0                      24^†^            176              250              93               126^††^          38               0                0                0                

  **48 to 58** (4,287)       0                      17^†^            311              218              176              3,525            40               0                0                0                

  **58 to 68** (6,535)       0                      3^†^             22^†^            511              431              5,375            52^††^           144^††^          0                0                

  **68 to 78** (5,515)       0                      0                0                656              358              3,351            129              195              672              154              

  **78 to 98** (421)         0                      0                0                28^†^            50               20^†^            18^†^            47               0                258              
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

MRi-Share, magnetic resonance imaging subcohort of Internet-based Students HeAlth Research Enterprise; BIL&GIN, Brain Imaging of Lateralization study at Groupe d\'Imagerie Neurofonctionnelle; SYS cohort, Saguenay Youth Study; ASPSF, Austrian Stroke Prevention Study Family; OATS, Older Australian Twin Study; LBC 1936, Lothian Birth Cohort; MAS, Memory and Ageing Study; TIV, total intracranial volume estimated with Freesurfer 5.3 version except "\*" with FreeSurfer 6.0 version. ^†^data subsample size \< 30 (not included in the age category statistical analysis).

Diffusion-Weighted Image Acquisition and Preprocessing {#s2_2}
------------------------------------------------------

[**Table 2**](#T2){ref-type="table"} summarize the main characteristics of the DWI acquisition and preprocessing for the 10 cohorts. Overall, there was considerable variability between studies regarding almost all acquisition parameters, including scanner manufacturer, field strength, gradient strength, diffusion pulse sequence, resolution, and number of directions. For the present work, it was not possible to access raw DWI data at different sites in order to harmonize processing from the initial DICOM data. For this reason, DWI data sets were pre-processed with procedures specific to each site, including exclusion of data upon visual detection of major artifacts due to eddy current distortions or head motion. AD, RD, MD, and FA maps were computed by fitting the DTI model parameters in each voxel from these preprocessed DWI volumes. Additional details on DWI preprocessing and DTI parameter map computation for each data set are provided in the [**Supplementary Material**](#SM1){ref-type="supplementary-material"} section.

###### 

Diffusion-weighted imaging acquisition the 10 contributing data sets.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Data set                   MRi-Share         BIL&GIN           SYS             LIFE              1000 BRAINS        UKBiobank             ASPSF              OATS              LBC 1936                MAS
  -------------------------- ----------------- ----------------- --------------- ----------------- ------------------ --------------------- ------------------ ----------------- ----------------------- ------------------
  **MRI scanner**            SIEMENS PRISMA    PHILIPS ACHIEVA   SIEMENS         SIEMENS VERIO     SIEMENS TIM TRIO   SIEMENS SKYRA         SIEMENS TIM TRIO   PHILIPS (x2)\     GE Signa Horizon HDxt   PHILIPS ACHIEVA\
                                                                                                                                                               SIEMENS(x2)                               Quasar Dual

  **B0 strength**            3T                3T                1.5T            3T                3T                 3T                    3T                 1.5T & 3T         1.5T                    3T

  **b-gradient (s/mm^2^)**   1000\*            1000              1000            1000              1000               1000\*                1000               1000              1000                    700 or 1000

  **Nr of directions**       32                2 x 21            64              60                30                 50                    6 or 12            32                64                      6 or 32

  **Voxel size (mm^3^)**     1.7 × 1.7 × 1.8   2 × 2 × 2         2.3 × 2.3 × 3   1.7 × 1.7 × 1.7   2 × 2 × 2          2 × 2 × 2             1.8 × 1.8 × 2.5    2.5 × 2.5 × 2.5   2 × 2 × 2               2.5 × 2.5 × 2.5

  **TR (ms)**                3540\             8500              8000            13,800            7800               3600 (multiband ×3)   4900 or 6700       7800 or 8600      16500                   7800
                             (multiband × 3)                                                                                                                                                             

  **TE (ms)**                75                81                102             100               83                 92                    81 or 95           68 or 96          98                      68

  **Acquisition duration**   9\'45             7\'45             10\'            16\'08            4\'30              9\'45                 4\'51 or 6\'10     4\'40 or 4\'56    19\'30                  4\'40
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

see [**Table 1**](#T1){ref-type="table"} legend for the meaning of data set abbreviated names and [**Supplementary Material**](#SM1){ref-type="supplementary-material"} section for a more detailed description of these data sets.

\*Multi-shell acquisition.

Derivation of DTI Metrics {#s2_3}
-------------------------

Various metrics were derived from the DTI data using a script developed by Baykara et al. (<http://www.psmd-marker.com>) ([@B20]). This original script was designed to extract PSMD, an index of the dispersion of MD values across the white matter skeleton. Briefly, the computation included two steps: 1) WM skeletonizing using the FA map, and 2) analyzing the voxel value distribution histogram in the MD volume masked by the WM-FA skeleton. The 3D brain image of FA of each individual was skeletonized using the FSL-TBSS software, part of the FMRIB Software Library (FSL) ([@B23], [@B24]), using the FMRIB 1 mm FA template and applying a 0.2 threshold on FA maps. Then the MD volume of the same individual was masked, keeping only voxels within the FA skeleton. Furthermore, in order to reduce contamination of the skeleton by CSF voxels, the FA-masked MD volumes were further masked by both a standard FA skeleton with a threshold of 0.3 on FA values and a custom mask (provided with the PSMD software tool) designed so as to exclude regions adjacent to the ventricles, such as the fornix. Finally, PSMD was computed as the difference between the 95th and 5th percentiles of the so-masked MD volume voxel value distribution. Here, we extended this script in order to obtain, in addition to PSMD values, estimates of the mean values of axial, radial, and mean diffusivity (AD, RD, MD, respectively) as well as of FA over the same customized skeleton. All 10 cohorts were processed separately with this customized script, and the results were sent to the Bordeaux site where they were combined for further statistical analysis.

Statistical Analyses {#s2_4}
--------------------

### Age Category Definition {#s2_4_1}

Due to previously reported non-linear effects of age on DTI metrics ([@B1], [@B3], [@B8]), we divided each cohort sample into subsamples of 10-year age range starting at 18 years of age, the last subsample (i.e. \[78 to 98\]) including all subjects older than 78 years, as there was only a small number of individuals older than 88 years. [**Table 1**](#T1){ref-type="table"} and [**Figure 1**](#f1){ref-type="fig"} detail the contribution of each cohort to each age category. Because we planned running analyses at the age category by cohort by sex level, we discarded subsamples of small sizes, namely, containing less than 30 individuals.

![Box-plots and histogram distribution of the age of the participants of the 10 contributing data sets.](fpsyt-11-00342-g001){#f1}

### Assessing Age-Related Changes of PSMD and Other DTI Metrics {#s2_4_2}

For each of the five DTI metrics and each age category, we performed an analysis of variance including "age" as the main effect, and "sex," total intracranial volume (TIV), and "Cohort" as confounding factors. The Cohort effect was included in order to account for apparent large differences in DTI metric average values across cohorts contributing to the same age category data set (see [**Figure 2**](#f2){ref-type="fig"}). "Sex" and "TIV" were included as covariates since mixed results have been reported regarding the impact of sex and TIV on DTI measures \[([@B12], [@B25]--[@B28]), see review in ([@B3])\]. In order to document differences of age effects between cohorts contributing to the same age category, we also performed an analysis of variance for each age category and each cohort, including "age," "sex," and "TIV" as effects. Moreover, we analyzed the effects of age on DTI metrics in men and women separately.

![Mean and standard deviation (bars) of the five DTI metrics for each age subcategory and each data set. The dotted lines connect values for the different age categories of the same data set.](fpsyt-11-00342-g002){#f2}

### Assessing the Effects of Sex and TIV on PSMD and Other DTI Metrics {#s2_4_3}

For each of the five DTI metrics and each age category, we also performed an analysis of variance including "Sex" and "TIV" as main factors and "Cohort" as confounding factors.

All statistical analyses were performed using the JMP Pro Software (version 14.3.0, SAS Institute Inc.).

Results {#s3}
=======

Descriptive Statistics {#s3_1}
----------------------

[**Tables 3A--E**](#T3a){ref-type="table"} provide basic statistics across age categories and cohorts for PSMD and the four other DTI metrics, while [**Figure 2**](#f2){ref-type="fig"} illustrates their respective profiles across the adult lifespan. From both [**Table 3**](#T3a){ref-type="table"} and [**Figure 2**](#f2){ref-type="fig"}, it is apparent that there is considerable variability in all five DTI parameter values, and that within a given age category the variability across cohorts is larger than the variability between individuals of the same cohort (see the extreme case of AD and FA values for the LBC1936 study performed at 1.5T, for example).

###### 

Basic statistics of axial diffusivity (AD, in mm^2^ s^−1^ × 10^−4^) average across a white matter skeleton for each age category and each contributing data set.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Age range      MRi-Share          BIL&GIN            SYS                LIFE               1000 BRAINS        UKBiobank          ASPSF              OATS               LBC 1936          MAS
  -------------- ------------------ ------------------ ------------------ ------------------ ------------------ ------------------ ------------------ ------------------ ----------------- ------------------
  **18 to 28**   11.80 (0.19)\      12.70 (0.18)\                         12.39 (0.23)\      11.60 (0.20)\                                                                                 
                 \[10.87, 12.45\]   \[12.26, 13.18\]                      \[11.70, 13.10\]   \[11.09, 11.96\]                                                                              

  **28 to 38**   11.68 (0.21)\      12.58 (0.17)\                         12.33 (0.20)\      11.41 (0.27)\                                                                                 
                 \[11.10, 12.12\]   \[12.14, 13.04\]                      \[11.80, 12.90\]   \[10.71, 11.95\]                                                                              

  **38 to 48**                      12.45 (0.21)\      11.58 (0.22)\      12.25 (0.21)\      11.33 (0.25)\      12.21 (0.27)\      11.88 (0.24)\                                           
                                    \[12.07, 12.88\]   \[11.03, 12.29\]   \[11.60, 12.80\]   \[10.52, 11.89\]   \[10.76, 12.85\]   \[11.50, 12.46\]                                        

  **48 to 58**                                         11.58 (0.23)\      12.25 (0.24)\      11.31 (0.25)\      12.21 (0.25)\      11.89 (0.27)\                                           
                                                       \[11.01, 12.38\]   \[11.40, 13.10\]   \[10.59, 12.02\]   \[10.18, 13.03\]   \[11.42, 12.68\]                                        

  **58 to 68**                                         11.67 (0.24)\      12.34 (0.26)\      11.37 (0.30)\      12.25 (0.26)\      12.03 (0.30)\      11.74 (0.49)\                        
                                                       \[11.24, 12.21\]   \[11.60, 13.20\]   \[10.30, 12.32\]   \[10.52, 13.24\]   \[11.41, 12.76\]   \[10.61, 12.80\]                     

  **68 to 78**                                                            12.48 (0.28)\      11.50 (0.32)\      12.34 (0.29)\      12.06 (0.37)\      11.83 (0.58)\      9.79 (0.43)\      11.83 (0.31)\
                                                                          \[11.40, 13.40\]   \[10.36, 12.58\]   \[10.70, 13.53\]   \[9.69, 12.88\]    \[10.69, 13.18\]   \[8.41, 10.94\]   \[11.06, 12.56\]

  **78 to 98**                                                            12.49 (0.30)\      11.64 (0.33)\      12.44 (0.27)\                         12.12 (0.62)\                        11.96 (0.32)\
                                                                          \[11.90, 13.20\]   \[11.07, 12.47\]   \[11.66, 12.83\]                      \[10.80, 13.49\]                     \[10.99, 13.05\]
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Values are mean (S.D. and range \[min, max\] across the age category sample). See [**Table 1**](#T1){ref-type="table"} legend for the meaning of data set abbreviated names.

###### 

Basic statistics of radial diffusivity (RD, in mm^2^ s^−1^ × 10^−4^) average across a white matter skeleton for each age category and each contributing data set.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Age range      MRi-Share        BIL&GIN          SYS              LIFE             1000 BRAINS      UKBiobank        ASPSF            OATS             LBC 1936         MAS
  -------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ----------------
  **18 to 28**   4.74 (0.18)\     4.81 (0.19)\                      4.83 (0.19)\     4.66 (0.18)\                                                                         
                 \[4.15, 5.53\]   \[4.26, 5.44\]                    \[4.33, 5.29\]   \[4.26, 5.19\]                                                                       

  **28 to 38**   4.72 (0.21)\     4.79 (0.20)\                      4.83 (0.20)\     4.60 (0.18)\                                                                         
                 \[4.35, 5.10\]   \[4.45, 5.56\]                    \[4.42, 5.36\]   \[4.20, 5.17\]                                                                       

  **38 to 48**                    4.83 (0.22)\     5.45 (0.24)\     4.87 (0.22)\     4.64 (0.20)\     4.95 (0.22)\     5.11 (0.29)\                                       
                                  \[4.49, 5.27\]   \[4.88, 6.36\]   \[4.35, 5.59\]   \[4.28, 5.27\]   \[4.19, 5.64\]   \[4.54, 5.79\]                                     

  **48 to 58**                                     5.51 (0.25)\     4.99 (0.24)\     4.72 (0.22)\     4.97 (0.23)\     5.22 (0.30)\                                       
                                                   \[4.93, 6.54\]   \[4.47, 6.01\]   \[4.21, 5.38\]   \[4.17, 6.22\]   \[4.57, 6.05\]                                     

  **58 to 68**                                     5.58 (0.31)\     5.13 (0.29)\     4.84 (0.25)\     5.08 (0.26)\     5.47 (0.37)\     5.27 (0.38)\                      
                                                   \[5.02, 6.27\]   \[4.29, 6.36\]   \[4.21, 5.57\]   \[4.34, 6.40\]   \[4.73, 6.59\]   \[4.36, 6.05\]                    

  **68 to 78**                                                      5.31 (0.33)\     4.99 (0.31)\     5.21 (0.29)\     5.49 (0.35)\     5.40 (0.46)\     5.21 (0.38)\     5.66 (0.34)\
                                                                    \[4.48, 6.73\]   \[4.16, 6.29\]   \[4.29, 7.10\]   \[4.85, 6.69\]   \[4.44, 6.77\]   \[4.28, 8.87\]   \[5.05, 6.78\]

  **78 to 98**                                                      5.37 (0.33)\     5.19 (0.37)\     5.36 (0.20)\                      5.75 (0.48)\                      5.81 (0.40)\
                                                                    \[4.87, 6.31\]   \[4.69, 5.99\]   \[5.03, 5.69\]                    \[4.80, 7.08\]                    \[4.88, 7.17\]
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Values are mean (S.D. and range \[min, max\] across the age category sample (see [**Table 1**](#T1){ref-type="table"} legend for the meaning of data set abbreviated names).

###### 

Basic statistics of mean diffusivity (MD, in mm^2^ s^−1^ × 10^−4^) average across a white matter skeleton for each age category and each contributing data set.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Age range      MRi-Share        BIL&GIN          SYS              LIFE             1000 BRAINS      UKBiobank        ASPSF            OATS             LBC 1936         MAS
  -------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ----------------
  **18 to 28**   7.09 (0.16)\     7.44 (0.17)\                      7.35 (0.18)\     6.97 (0.17)\                                                                         
                 \[6.54, 7.76\]   \[7.02, 7.98\]                    \[6.89, 7.75\]   \[6.54, 7.34\]                                                                       

  **28 to 38**   7.04 (0.18)\     7.39 (0.17)\                      7.33 (0.18)\     6.87 (0.19)\                                                                         
                 \[6.64, 7.38\]   \[7.08, 7.97\]                    \[6.92, 7.78\]   \[6.43, 7.39\]                                                                       

  **38 to 48**                    7.37 (0.20)\     7.50 (0.21)\     7.33 (0.20)\     6.87 (0.19)\     7.37 (0.22)\     7.37 (0.25)\                                       
                                  \[7.05, 7.80\]   \[6.98, 8.17\]   \[6.81, 7.84\]   \[6.42, 7.39\]   \[6.38, 8.05\]   \[6.97, 8.01\]                                     

  **48 to 58**                                     7.53 (0.23)\     7.41 (0.22)\     6.92 (0.21)\     7.39 (0.22)\     7.45 (0.27)\                                       
                                                   \[6.97, 8.45\]   \[6.89, 8.31\]   \[6.35, 7.58\]   \[6.17, 8.42\]   \[6.91, 8.26\]                                     

  **58 to 68**                                     7.61 (0.27)\     7.53 (0.26)\     7.01 (0.25)\     7.47 (0.24)\     7.66 (0.34)\     7.43 (0.41)\                      
                                                   \[7.09, 8.20\]   \[6.82, 8.64\]   \[6.35, 7.78\]   \[6.41, 8.67\]   \[6.98, 8.58\]   \[6.55, 8.18\]                    

  **68 to 78**                                                      7.70 (0.30)\     7.16 (0.29)\     7.59 (0.27)\     7.68 (0.33)\     7.54 (0.48)\     6.74 (0.35)\     7.72 (0.31)\
                                                                    \[6.93, 8.92\]   \[6.30, 8.39\]   \[6.43, 9.23\]   \[6.51, 8.74\]   \[6.57, 8.91\]   \[5.79, 7.86\]   \[7.14, 8.71\]

  **78 to 98**                                                      7.74 (0.31)\     7.34 (0.34)\     7.72 (0.20)\                      7.87 (0.51)\                      7.86 (0.36)\
                                                                    \[7.23, 8.61\]   \[6.84, 8.15\]   \[7.34, 8.01\]                    \[6.92, 9.21\]                    \[6.96, 9.06\]
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Values are mean (S.D. and range \[min, max\] across the age category sample (see [**Table 1**](#T1){ref-type="table"} legend for the meaning of data set abbreviated names).

###### 

Basic statistics of peak width skeletonized mean diffusivity (PSMD, in mm^2^ s^−1^ × 10^−4^) for each age category and each contributing data set.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Age range      MRi-Share        BIL&GIN          SYS              LIFE             1000 BRAINS      UKBiobank        ASPSF            OATS             LBC 1936         MAS
  -------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ----------------
  **18 to 28**   1.54 (0.14)\     2.13 (0.17)\                      2.02 (0.19)\     2.26 (0.28)\                                                                         
                 \[1.20, 2.13\]   \[1.75, 2.78\]                    \[1.68, 2.53\]   \[1.86, 3.47\]                                                                       

  **28 to 38**   1.58 (0.17)\     2.18 (0.22)\                      2.05 (0.19)\     2.32 (0.24)\                                                                         
                 \[1.33, 2.01\]   \[1.75, 2.85\]                    \[1.65, 2.63\]   \[1.75, 3.00\]                                                                       

  **38 to 48**                    2.24 (0.18)\     2.68 (0.30)\     2.17 (0.22)\     2.49 (0.29)\     2.10 (0.22)\     2.63 (0.39)\                                       
                                  \[1.89, 2.58\]   \[2.07, 4.44\]   \[1.64, 3.00\]   \[1.94, 3.46\]   \[1.60, 3.11\]   \[1.95, 3.53\]                                     

  **48 to 58**                                     2.82 (0.34)\     2.31 (0.28)\     2.67 (0.32)\     2.12 (0.25)\     2.69 (0.36)\                                       
                                                   \[1.99, 5.12\]   \[1.70, 3.63\]   \[2.03, 4.07\]   \[1.49, 4.58\]   \[2.18, 3.70\]                                     

  **58 to 68**                                     2.92 (0.30)\     2.53 (0.38)\     2.94 (0.38)\     2.27 (0.31)\     2.82 (0.49)\     2.96 (0.54)\                      
                                                   \[2.51, 3.57\]   \[1.83, 4.85\]   \[2.14, 5.03\]   \[1.56, 5.71\]   \[2.15, 4.54\]   \[2.11, 4.90\]                    

  **68 to 78**                                                      2.78 (0.47)\     3.26 (0.47)\     2.48 (0.39)\     3.17 (0.49)\     3.10 (0.64)\     3.18 (0.53)\     3.84 (0.61)\
                                                                    \[1.88, 5.26\]   \[2.23, 5.53\]   \[1.61, 6.19\]   \[2.15, 4.60\]   \[2.17, 6.66\]   \[2.09, 5.72\]   \[2.56, 6.02\]

  **78 to 98**                                                      2.96 (0.45)\     3.68 (0.58)\     2.74 (0.33)\                      3.77 (0.90)\                      4.29 (0.77)\
                                                                    \[2.15, 3.94\]   \[2.83, 5.32\]   \[2.10, 3.45\]                    \[2.47, 6.51\]                    \[2.95, 7.96\]
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Values are mean (S.D. and range \[min, max\] across the age category sample (see [**Table 1**](#T1){ref-type="table"} legend for the meaning of data set abbreviated names).

###### 

Basic statistics of fractional anisotropy (FA, unitless) average across individual FA skeleton for each age range category and each contributing data set.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Age range      MRi-Share        BIL&GIN          SYS              LIFE             1000 BRAINS      UKBiobank        ASPSF            OATS             LBC 1936         MAS
  -------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ----------------
  **18 to 28**   0.53 (0.01)\     0.56 (0.01)\                      0.54 (0.02)\     0.54 (0.01)\                                                                         
                 \[0.47, 0.58\]   \[0.51, 0.60\]                    \[0.49, 0.58\]   \[0.49, 0.56\]                                                                       

  **28 to 38**   0.53 (0.02)\     0.55 (0.02)\                      0.54 (0.02)\     0.54 (0.01)\                                                                         
                 \[0.49, 0.56\]   \[0.50, 0.58\]                    \[0.50, 0.58\]   \[0.49, 0.57\]                                                                       

  **38 to 48**                    0.55 (0.02)\     0.46 (0.02)\     0.54 (0.02)\     0.53 (0.02)\     0.53 (0.01)\     0.51 (0.02)\                                       
                                  \[0.52, 0.57\]   \[0.39, 0.50\]   \[0.48, 0.58\]   \[0.48, 0.56\]   \[0.49, 0.56\]   \[0.46, 0.55\]                                     

  **48 to 58**                                     0.45 (0.02)\     0.53 (0.02)\     0.52 (0.02)\     0.52 (0.02)\     0.49 (0.02)\                                       
                                                   \[0.40, 0.50\]   \[0.46, 0.57\]   \[0.47, 0.58\]   \[0.44, 0.57\]   \[0.42, 0.54\]                                     

  **58 to 68**                                     0.45 (0.02)\     0.52 (0.02)\     0.51 (0.02)\     0.52 (0.02)\     0.48 (0.02)\     0.48 (0.02)\                      
                                                   \[0.41, 0.49\]   \[0.44, 0.58\]   \[0.46, 0.57\]   \[0.44, 0.57\]   \[0.41, 0.53\]   \[0.43, 0.55\]                    

  **68 to 78**                                                      0.51 (0.02)\     0.51 (0.02)\     0.51 (0.02)\     0.48 (0.02)\     0.48 (0.03)\     0.41 (0.03)\     0.45 (0.02)\
                                                                    \[0.40, 0.56\]   \[0.44, 0.56\]   \[0.37, 0.57\]   \[0.41, 0.53\]   \[0.38, 0.54\]   \[0.31, 0.47\]   \[0.36, 0.49\]

  **78 to 98**                                                      0.50 (0.02)\     0.50 (0.02)\     0.50 (0.01)\                      0.46 (0.02)\                      0.45 (0.03)\
                                                                    \[0.45, 0.54\]   \[0.44, 0.53\]   \[0.48, 0.52\]                    \[0.40, 0.51\]                    \[0.34, 0.51\]
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Values are mean (S.D. and range \[min, max\] across the age category sample (see [**Table 1**](#T1){ref-type="table"} legend for the meaning of data set abbreviated names).

[**Figure 3**](#f3){ref-type="fig"} compares the inter-individual variability of PSMD (in terms of its coefficient of variation, CV in %) within each cohort to those of the other DTI metrics, again for each age category and each cohort, revealing that PSMD CV\'s is in the order of 10% to 15% (with values as high as 20% for later ages) while those for AD, RD, MD, and FA are in the order of 2% to 5%. Note also that the CVs of all DTI metrics increase with age, more for PSMD than for the other parameters.

![Coefficients of variation of the five DTI metrics for each age subcategory and each data set.](fpsyt-11-00342-g003){#f3}

Effects of Age on PSMD and Other DTI Metrics {#s3_2}
--------------------------------------------

The evolution of PSMD across the adult life is different from that of the other metrics ([**Figure 2**](#f2){ref-type="fig"}). Indeed, PSMD seems to increase monotonically with age, whereas AD, RD, and MD exhibit a similar J-shape profile, initially slightly decreasing during post-adolescence before later increasing during adulthood. As for FA, it shows a reverse profile to that of AD, RD, and MD, with an initial small increase followed by a later decrease.

This apparent specific lifespan profile of PSMD was confirmed by the quantitative estimates of the effects of age on PSMD and other DTI metrics provided by the between-cohort ANOVA (see [**Table 4**](#T4){ref-type="table"}) and their profiles of evolution across age categories as shown in [**Figure 4**](#f4){ref-type="fig"}. Estimates of the age effect on PSMD were indeed positive for all age categories and significant for all but the 28- to 38-year age period. This increase in PSMD accelerated during late life periods, its value being multiplied by a factor of 3 between the 58- to 68-year and the 78- to 98-year periods. By contrast, AD, RD, and MD age variation profiles were characterized by an initial small but significant decrease (negative age effect), followed by a stable period (non-significant age effect) and a final significant increase (positive age effect). What distinguished AD, RD, and MD profiles was their respective timings, the initial decrease in RD and MD being significant only for the 18 to 28 years subsample, while it extended over the 38- to 48-year period for AD. Note that since the stable period covered two periods of 10 years for all three metrics, the increase in AD was delayed by 10 years compared with RD and MD. At the same time, FA exhibited the reverse contrast consisting of an initial increase during the 18- to 28-year period followed by a stable period (28 to 38 years) before an accelerated decrease during the rest of the adult life course. The age effects on DTI metrics were not significantly different between men and women as revealed by the separate sex-specific analyses of age effects.

###### 

ANOVA effect of age (estimate (standard error) and significance p-value) on five DTI metrics (AD, RD, MD, PSMD, and FA evaluated across individual FA skeletons).

  Age range (years)   AD             RD         MD              PSMD       FA                                                                 
  ------------------- -------------- ---------- --------------- ---------- --------------- ---------- ------------- ---------- -------------- ----------
  **18 to 28**        −2.01 (0.20)   \<0.0001   −1.06 (0.18)    \<0.0001   −1.38 (0.17)    \<0.0001   0.41 (0.15)   0.0058     0.30 (0.15)    0.041
  **28 to 38**        −1.32 (0.43)   0.0023     −0.22 (0.41).   0.59       −0.58 (0.37)    0.12       0.60 (0.42)   0.15       −0.27 (0.32)   0.40
  **38 to 48**        −0.68 (0.37)   0.065      0.40 (0.37)     0.27       0.047 (0.33).   0.89       1.84 (0.41)   \<0.0001   −0.54 (0.27)   0.046
  **48 to 58**        −0.11 (0.13)   0.41       0.61 (0.12)     \<0.0001   0.37 (0.12)     0.0019     1.11 (0.14)   \<0.0001   −0.56 (0.09)   \<0.0001
  **58 to 68**        0.95 (0.12)    \<0.0001   1.46 (0.11)     \<0.0001   1.29 (0.11)     \<0.0001   2.18 (0.14)   \<0.0001   −0.91 (0.08)   \<0.0001
  **68 to 78**        1.75 (0.19)    \<0.0001   1.94 (0.18)     \<0.0001   1.87 (0.17)     \<0.0001   3.67 (0.24)   \<0.0001   −0.97 (0.12)   \<0.0001
  **78 to 98**        2.30 (0.60)    0.0002     4.01 (0.64)     \<0.0001   3.44 (0.59)     \<0.0001   6.99 (0.12)   \<0.0001   −2.36 (0.39)   \<0.0001

Values are in mm^2^ s^−1^ year^-−1^ × 10^−6^ for AD, RD, and MD, in mm^2^ s^−1^ year^−1^ × 10^−7^ for PSMD, and in year^−1^ × 10^−3^ for FA.

![ANOVA estimates and 95% confidence intervals of the effects of age on the five DT metrics for each age subcategory. Units are mm^2^/s/year × 10^−3^ for AD, RD, and MD, mm^2^/s/year × 10^−4^ for PSMD, year × 10^−3^ for FA.](fpsyt-11-00342-g004){#f4}

Effects of Sex and TIV on DTI {#s3_3}
-----------------------------

Amplitude of sex effects on DTI metric average values were found to be quite variable across the various cohorts for the different age categories (see [**Figure 5**](#f5){ref-type="fig"}). When pooling all data sets, we found that sex had significant effects on all DTI parameters except on FA. Women had higher mean AD and MD values than men, who conversely had higher PSMD values than women (see [**Table 5**](#T5){ref-type="table"}). As for TIV, we found that it had positive effects on all DTI parameters (see [**Table 5**](#T5){ref-type="table"}), including PSMD, these effects being very significant (*p* \< 10^−4^) in all cases but RD (*p* = 0.53).

![ANOVA estimates and 95% confidence intervals of the effects of sex (females minus males) on the five DT metrics for each age subcategory and each data set.](fpsyt-11-00342-g005){#f5}

###### 

ANOVA effect of sex and TIV (estimate (standard error) and significance p value) on five DTI metrics (AD, RD, MD, PSMD, and FA evaluated across individual FA skeletons).

                  AD            RD         MD             PSMD    FA                                                                
  --------------- ------------- ---------- -------------- ------- ------------- ---------- -------------- ---------- -------------- ----------
  **Sex (F-M)**   1.13 (0.21)   \<0.0001   0.45 (0.21)    0.032   0.68 (0.19)   0.0005     −5.34 (0.26)   \<0.0001   0.04 (0.14).   0.74
  **TIV**         1.41 (0.12)   \<0.0001   0.07 (0.12).   0.53    0.52 (0.01)   \<0.0001   1.43 (0.15)    \<0.0001   0.54 (0.08)    \<0.0001

Values for the effects of sex are in mm^2^ s^−1^ × 10^−6^ for AD, RD, MD, and PSMD and in ×10^−3^ for FA, and for the effects of TIV are in mm^2^ s^−1^ cm^−3^ × 10^−6^ for AD, RD MD, and PSMD and in cm^−3^ × 10^−5^ for FA.

Discussion {#s4}
==========

We will first discuss methodological issues and potential limitations in interpreting results of our study. Second, we will discuss what the present study adds to the already existing literature on age effects on classical DTI parameters. In the third part, we will focus on the original findings regarding PSMD distribution and evolution over the adult life.

Methodological Issues and Potential Limitations of the Present Study {#s4_1}
--------------------------------------------------------------------

In order to study the effects of age over the entire adult lifespan, we gathered DTI data from 20,005 individuals scanned at 10 different sites with the major objective of maximizing statistical power. By so doing, we were aware that the variability of DTI parameters derived from the entire data set would be much larger than for a single-site study because of between-site differences in data acquisition protocols, such as scanner manufacturer, field strength, number and strength of diffusion-encoding gradients, image voxel size, post-processing of raw DWI data, and so on ([@B23], [@B24], [@B29]--[@B32]). Accordingly, a key issue was to reduce as much as possible the variability due to sources that were controllable so that we could maximize benefits of the very large sample size.

Concerns with DTI multi-site studies have been emphasized by several authors ([@B33], [@B34]) and strategies have been proposed for harmonizing DWI data before proceeding to statistical analysis of DTI parameter maps. However, it has also been reported that DTI parameters estimated over the whole white matter or large regions of interest actually exhibit high intra- and inter-scanner reproducibility, making them suitable for multisite studies without extensive harmonization ([@B17], [@B35], [@B36]). This is the approach that we implemented here as it was not possible to access raw DWI data at different sites in order to harmonize processing from the very earliest stages (see [**Supplementary Materials**](#SM1){ref-type="supplementary-material"}). In our study, harmonization was limited to the post-processing of DTI maps pre-computed by each site using the same script for generating individual skeletons and computing individual DTI parameter values across these skeletons. However, our findings indicate that it is possible to draw meaningful conclusions from such minimal harmonization by focusing on the effects of interest (age in our case) rather than the absolute values of the measurements, an approach previously used by others ([@B37]).

Multi-site studies do have some advantages as compared with single-site investigations, namely, statistical power due to very large sample size, and the ability to recruit a sufficient number of individuals over the entire life or adult lifespan. As emphasized by others, these are important features in the context of clinical studies that are often multisite in nature ([@B17], [@B35]). In fact, there have been several previous reports of multisite studies on DTI parameters in adults but they dealt with issues other than age effects such as methodology ([@B17], [@B30], [@B33]) and genetic effects ([@B38], [@B39]), for example.

In this study, we focused on the mean DTI metrics over a white matter skeleton, rather than over the entire white-matter compartment, since our primary metric of interest was PSMD, which is defined over the FSL-TBSS white matter skeleton derived from FA data. This approach should in theory minimize any partial volume effects by limiting the measurement over the core of white matter tracts. Indeed, when we compared the mean DTI metrics over the white matter skeleton with those measured over the whole white-matter compartment in two cohorts of the study (MRi-Share and BIL&GIN), mean FA values were higher and diffusivity values were lower when averaged over the white matter skeleton than when averaged over the entire white-matter compartment. However, the cross-subject variability measured as the CV of the mean DTI metrics decreased only marginally (a fraction of a percent for CVs ranging from 2% to 4%) when mean values were computed over the white matter skeleton rather than the whole white matter. In contrast, the CV of PSMD decreased markedly (on average, from 24% to 8%) when its computation was performed on the white matter skeleton rather than on than the global white-matter mask. This demonstrates the importance of choosing a measure of MD dispersion values over a white matter skeleton for controlling between subject variability.

In the present work, we restricted the analysis to classical DTI metrics as only two of the contributing cohorts had high angular resolution and/or multi-shell acquisition schemes that could be used for estimating advanced white-matter microstructural parameters with more sophisticated models ([@B29]). Here, DWI data processing was solely based on the classical DTI model. The DTI model limitations are well known ([@B24]), and it has been shown, for example, that correction for free water has a major impact on classical DTI parameter values ([@B40], [@B41]). However, although investigating advanced white-matter microstructural parameters is highly desirable, it was beyond the scope of our study: it would require additional data sets with multi-shell acquisition, especially for individuals aged 30 to 50 years or over 70 years, in order to supplement existing data ([@B8]) on the adult lifespan trajectory of these microstructural parameters.

Mixed results have been reported regarding the impact of sex and TIV on DTI measures \[([@B12], [@B25]--[@B28]), see review in ([@B3])\]. Here, we also observed mixed results across the different cohorts, although very significant sex effects on all DTI parameters, except FA, were uncovered when combining the entire data set. Note, however, these sex effects were of very small size (for PSMD, for example, omega^2^ = 6.7 × 10^−3^ for the sex effect to be compared with 7.6 × 10^−2^ for the age effect), which could explain the mixed findings in the literature, and suggests further investigations are required in order to understand their biological origins. TIV effects on DTI parameters are not well established in the literature. In our study, we found that TIV was positively correlated with all DTI parameters except for RD. Similar to sex, TIV effects when significant were very small (for PSMD again, omega^2^ = 1.5 × 10^−3^ for the TIV effect). Here again additional investigations are needed to understand the origins of these effects.

Finally, and importantly, it should be stressed that interpretation of the results of the present study should be taken with caution because of the cross-sectional nature of the data that we analyzed. Numerous reports have indeed pointed out the caveats of cross-sectional design for assessing effects of age and demonstrated how such design may lead to spurious findings when compared to those obtained with longitudinal data ([@B12], [@B42], [@B43]). In the present work, there was no attempt to use a single model to describe the variation of DTI parameters with age over the entire adulthood period. Rather, we selected a piecewise linear model to examine/compare age-related changes in 10-year duration consecutive time bins, thereby minimizing the generation bias between cohorts of nearby categories. Understandably, such an approach does not eradicate the intrinsic limits of our cross-sectional study. But it should be reminded that a fully longitudinal design is quasi impossible to implement in the context of lifespan research, since, in practice, measures in an individual can be repeated only a few times and at short duration intervals. As a consequence, such longitudinal studies suffer from some of the limitations of cross-sectional ones. This may explain why the results of the present study are compatible with those a previously published longitudinal study ([@B12]) in which individuals aged between 20 and 84 years were observed twice 3 years apart.

Adult Lifespan Profiles of Variation of Classical DTI Parameters AD, RD, MD, and FA {#s4_2}
-----------------------------------------------------------------------------------

Effects of age on white-matter microstructure assessed with DTI have been intensively investigated over the past decade from a developmental perspective ([@B4]) as well as in a lifespan/ageing framework ([@B1], [@B3], [@B5], [@B8], [@B11], [@B12], [@B27], [@B40]). Briefly, and considering only DTI metrics estimated at the global level, AD, RD, and thus, MD were reported to follow similar U- or better J-shape age variation patterns, initially decreasing during childhood and adolescence (see ([@B4]) for review) then exhibiting an accelerated increase during the adult life ([@B8], [@B12]), while FA followed a reverse profile. Our own findings agree with this body of results during the adult life course. Raw data plots show J-shape profiles for AD, RD, and MD, and the reverse profile for FA, as well as acceleration of these changes during late life.

Maximum global FA values and minimum global MD, RD, and AD values have been reported to occur before the age of 40 years ([@B1], [@B5], [@B11], [@B12], [@B27]), although large variations were found when considering individual tracts ([@B5], [@B26], [@B44], [@B45]). Here, we found extreme values for RD, MD, and FA occurring between 28 and 38 years, well in line with these previous findings. In addition, we found that the decrease of AD in the post-adolescence period extended into adulthood by about 10 years more than for RD and MD, thereby uncovering heterochrony of AD and RD variations during adulthood. Such a heterochrony during adulthood was not detected in a previous longitudinal study ([@B12]) possibly due to an insufficient sample size and large DTI metric variability between individuals (as can be seen in Figure 7 of the mentioned report). Note that two recent studies ([@B46], [@B47]) have reported opposite age effects for AD (decrease) and RD (increase) with stable MD during the 18 to 55 year age period; however, as both studies used simple linear modeling due to small sample sizes, no age at extreme value could be observed. Rather, our findings are compatible with the AD-RD variation heterochrony that has been noticed earlier during childhood and adolescence at the individual tract level with stronger decrease for RD than for AD ([@B34], [@B44]). According to these and our findings, the AD decrease/RD increase profile ([@B6]) would occur only during mid-adulthood.

PSMD Is a Diffusion Imaging Phenotype With a Profile of Variation Across the Adult Lifespan That Differs From That of Other DTI Parameters {#s4_3}
------------------------------------------------------------------------------------------------------------------------------------------

The distribution of PSMD values observed for the different cohorts and age categories of the present study are consistent with the few comparable data reported in the literature for older participants (no data are available in young adults). For example, Baykara et al. reported in their pioneering article a PSMD median value around 3.0 (in mm^2^ s^−1^ × 10^−4^, range \[2.5, 4.9\]) in a sample of healthy individuals aged 60 to 80 years drawn from the ASPF cohort \[see [**Table 2**](#T2){ref-type="table"} of Baykara et al. ([@B20])\], values that are comparable to those reported in [**Table 3D**](#T3d){ref-type="table"} of our study in subsamples of other cohorts of similar age category. Similarly, Wei et al. ([@B21]) recently reported a PSMD average value of 2.4 × 10^−4^ mm^2^ s^−1^ in a sample of healthy controls aged around 60 years. In both studies, PSMD CVs were close to 10%, a value again similar to those observed in our own study. That the CV of PSMD is two to three times larger than the CVs of other DTI metrics could be expected since PSMD is a dispersion rather than a central tendency statistic. Moreover, the larger increase in PSMD CV as age advances (as compared to the other DTI metrics) indicates that this phenotype should be used with caution especially during the late life period. However, it is important to note that the CV of PSMD was found to be quite stable across cohorts with similar age ranges.

The main goal of the present study was to document the profile of PSMD evolution across age bands during adulthood. In this respect, and the proviso that the data we gathered were not longitudinal, our results show that PSMD increases continuously from post-adolescence to late adult life, that this increase is accelerating at later ages, and that this acceleration is larger than for the other DTI metrics. As there are no available data of PSMD in childhood and adolescence, it is not possible to decide whether the lifetime PSMD evolution profile is similar to those of AD, RD, MD, i.e. with a decrease during childhood that reaches the minimum value before adulthood, or if it shows continuous increase throughout the lifespan. Nevertheless, it remains the case that the continuous and accelerating increase of PSMD during adulthood is an indication that it is an adequate and potentially valuable marker of white matter ageing. In particular, it is notable that PSMD increases during early adulthood when the other DTI metrics variations appear to be still undergoing late maturational processes.

The biological mechanisms of the origin of PSMD evolution with age are at present unknown, but one can think of several reasons why PSMD may be more prone to increase with age as compared with the other metrics. First, it is important to remember that PSMD is a measure of MD values dispersion across a skeleton of white matter. As such, it will be directly affected by differences across MD values of the individual tracts. Consequently, regional heterogeneity as well as heterochrony in MD values of the fiber tracts will result in higher PSMD values more than in average MD values. Second, MD itself is a weighted average of AD (1/3) and RD (2/3) values, and thus MD value dispersion will also be affected by heterochrony in AD and RD variations with age. Overall, what possibly makes PSMD an early and sensitive imaging marker of ageing is that it captures multiple sources of heterogeneity in white matter water diffusion parameters. With this regard, it would be interesting to investigate variations in the pattern of MD dispersion at the regional level using tract-based DTI metrics since it is well established that heterochrony is a major feature of the development and aging of the different fiber tracts \[see for example ([@B5], [@B8], [@B26], [@B44])\]. Accordingly, variations of PSMD value provide only a gross and possibly biased estimate of the white matter-microstructure dynamics. We did not implement regional analysis as our study focused on PSMD that is by definition a dispersion statistic over the entire white matter skeleton. Nevertheless, a regional approach would certainly be interesting and feasible since peak width of MD values could be measured on a white-matter skeleton at the tract level in the same manner as it has been done for other DTI metrics (see ([@B34], [@B46]) for example).
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